P504S Immunostaining Boosts Diagnostic Resolution of "Suspicious" Foci in Prostatic Needle Biopsy Specimens

American Journal of Clinical Pathology

Volumn 121, Issue 1, 2004, Pages 99-107

  Jiang, Zhong ^a   Iczkowski, Kenneth A ^b,c   Woda, Bruce A ^a   Tretiakova, Maria ^d   Yang, Ximing J ^d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

AMACR; Atypical small acinar proliferation; Biopsy; P504S; Prostate cancer; Methylacyl CoA racemase

Indexed keywords

KERATIN;

ARTICLE; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 0347761214     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/7T7RJCCL84JGXH3L     Document Type: Article

References (23)

1. Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol. 1995;154:1791-1794.
2. Cheville JC, Reznicek MJ, Bostwick DG. The focus of atypical glands suspicious for malignancy in prostate needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol. 1997;108:633-640.
3. Hoedemaeker RF, Kraanse R, Rietbergen JB, et al. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions. Cancer. 1999;85:145-152.
4. Orozco R, O'Dowd G, Kunnel B, et al. Observations on pathology trends in 62,537 prostate biopsies obtained from urology practices in the United States. Urology. 1998;51:186-195.
5. Renshaw AA, Santis WF, Ritchie JP. Clinicopathologic characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol. 1998;159:2018-2022.
6. Rogatsch H, Mairinger T, Gschwendtner A, et al. Optimized preembedding method improves the histologic yield of prostatic core needle biopsies. Prostate. 2000;42:124-129.
7. Iczkowski KA, Bostwick DG. Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma: analytic comparison with nondiagnostic but suspicious, atypical small acinar proliferation. Arch Pathol Lab Med. 2000;124:98-107.
8. Iczkowski KA, Bassler TJ, Schwob VS, et al. Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer. Urology. 1998;51:749-758.
9. Iczkowski KA, MacLennan GT, Bostwick DG. Atypical small acinar proliferation of the prostate suspicious for malignancy in needle biopsies: histologic features and clinical significance in 33 cases. Am J Surg Pathol. 1997;21:1489-1495.
10. Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397-1404.
11. Jiang Z, Wu CL, Woda BA, et al. P504S/α-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002;26:1169-1174.
12. Rubin MA, Zhou M, Dhanasekaran SM, et al. α-Methyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287:1662-1670.
13. Beach R, Gown AM, de Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 2002;26:1588-1596.
14. Zhou M, Chinnaiyan AM, Kleer CG, et al. Alpha methylacyl-CoA racemase: a novel tumor marker overexpressed in several human cancers and their precursor lesions. Am J Surg Pathol. 2002;26:926-931.
15. Ramnani DM, Bostwick DG. Basal cell-specific anti-keratin antibody 34βE12: optimizing its use in distinguishing benign prostate and cancer [editorial]. Mod Pathol. 1999;12:443-444.
16. Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval on antibody 34βE12 immunostaining of prostatic tissues. Mod Pathol. 1999;12:472-478.
17. Rabbani F, Stroumbakis N, Kava BR, et al. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol. 1998;159:1247-1250.
18. Wojno KJ, Epstein JI. The utility of basal cell-specific anti-cytokeratin antibody 34βE12 in the diagnosis of prostate cancer: a review of 228 cases. Am J Surg Pathol. 1995;19:251-260.
19. Zhou M, Jiang Z, Epstein JI. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Am J Surg Pathol. 2003;27:772-778.
20. Farinola MA, Epstein JI. Utility of immunohistochemistry for alpha-methylacyl CoA racemase (AMACR) in distinguishing atrophic prostate cancer from benign atrophy [abstract]. Mod Pathol. 2003;16:149A.
21. Reyes AO, Humphrey PA. Diagnostic effect of complete histologic sampling of prostate needle biopsies. Am J Clin Pathol. 1998;109:416-422.
22. Novis DA, Zarbo RJ, Valenstein PA. Diagnostic uncertainty expressed in prostate needle biopsies: a College of American Pathologists Q-Probes study of 15,753 prostate needle biopsies in 332 institutions. Arch Pathol Lab Med. 1999;123:687-692.
23. Iczkowski KA, Chen HM, Yang XJ, et al. Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. Urology. 2002;60:851-854.